The surgical drapes and gowns market plays a vital role in ensuring safety, hygiene, and infection control during surgeries. Surgical drapes are used as barriers to create sterile fields around patients and medical equipment during surgical procedures, while surgical gowns provide protection to clinical staff from infection exposure and spread of microorganisms during surgical interventions. The growing volume of surgeries attributed to rising prevalence of chronic and lifestyle diseases along with increasing focus on patient safety and infection control in healthcare settings have been driving the demand for surgical drapes and gowns globally. The global surgical drapes and gowns Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 74.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing volume of surgeries across the globe due to rising prevalence of chronic and lifestyle diseases has been a major trend bolstering the growth of the surgical drapes and gowns market over the recent years. As per WHO estimates, over 313 million major surgical procedures are conducted annually worldwide. Moreover, surgical site infections account for over millions of cases and thousands of deaths every year, increasing the need for sterilization and infection control measures like surgical drapes and gowns during surgeries. The market has also witnessed innovations to develop infection-resistant and lightweight drapes and gowns to enhance surgical experience and patient outcomes. Leading players are focusing on new product launches catering to specific surgical needs to strengthen their market position.
Strength: Surgical drapes and gowns provide an effective barrier against infections during surgical procedures and maintain sterility. They help in creating a sterile field during surgery.
Weakness: Cost of specialized sterile surgical drapes and gowns is high which is a challenge especially for hospitals and healthcare facilities in developing regions. Raw materials for manufacturing surgical drapes and gowns are susceptible to price fluctuations.
Opportunity: Rising number of surgical procedures due to increasing incidences of chronic diseases and road accidents drives demand for surgical drapes and gowns. Growing healthcare infrastructure and expenditure in emerging economies present an opportunity.
Threats: Alternatives sterilization products and techniques can replace surgical drapes and gowns to some extent posing a threat. Stringent regulations pertaining to sterilization of surgical drapes and gowns add to production costs.
The Global Surgical Drapes And Gowns Market Scope is expected to witness high.
Regional analysis comprised of North America dominates the global surgical drapes and gowns market due to growing elderly population, high healthcare spending and rising number of surgeries in the region. The Asia Pacific region is expected to grow at the fastest pace during the forecast period due to increasing healthcare infrastructure, surgeries and focus on preventive healthcare in emerging economies like India and China.
Key players operating in the surgical drapes and gowns market are Orasis Pharmaceuticals, AbbVie Inc. (Allergan), Novartis AG, OSRX Pharmaceuticals, LENZ Therapeutics, Visus Therapeutics, Ocuphire Pharma Inc., Eyenovia, Inc., Vyluma Inc., and Jawa Pharmaceuticals (India) Pvt. Ltd. The global surgical drapes and gowns market is consolidated in nature with the top three players accounting for a majority market share. Industry players adopt strategies such as new product launches, mergers and acquisitions to strengthen market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it